MedPath

Certain Maternal Antibodies in Relation to Doppler in Hypertension With Pregnancy

Conditions
Pre-Eclampsia
Interventions
Diagnostic Test: Doppler
Diagnostic Test: serum antibodies
Registration Number
NCT03214393
Lead Sponsor
Cairo University
Brief Summary

Relation of certain maternal serum antibodies to Doppler changes will be studied in cases suffering from hypertension with pregnancy.

Detailed Description

Assessment will be done for maternal serum anti-beta 2 glycoprotein 1 antibodies and anticardiolipin antibodies in cases of preeclampsia after 32 weeks of pregnancy. In addition, fetal Doppler changes will be assessed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Pregnant women 32 weeks or more gestational age
  • Pre-eclampsia
  • Singleton pregnancy
Read More
Exclusion Criteria
  • Intrauterine fetal death
  • Fetus with apparent congenital anomalies
  • Pregnant females with other medical disorders
  • History of essential hypertension.
  • History of antepartum hemorrhage.
  • History of rupture of membranes.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pre-Eclampsiaserum antibodiespregnant women with Pre-Eclampsia will be assessed by serum antibodies and Doppler
Pre-EclampsiaDopplerpregnant women with Pre-Eclampsia will be assessed by serum antibodies and Doppler
Primary Outcome Measures
NameTimeMethod
percentage of cases that develop severe pre-eclampsiaIt will be calculated after 1 year from the start of the study

percentage of cases that develop severe pre-eclampsia will be assessed by an investigator

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Obstetrics and Gynecology

🇪🇬

Cairo, Greater Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath